◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2609

Bayzed Health Group Inc (2609) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-10

Bayzed Health Group Inc (2609) operates in the Medical Care Facilities industry and is headquartered in Beijing, China with about 1,998 employees. Its market capitalization is roughly CNY 4 billion. In the fiscal year ended 2025-12-31, 2609 reported CNY 1.1B in revenue and (CNY 13M) in net income.

Bayzed Health Group Inc operates and manages a network of hospitals that provides oncology medical and healthcare services in the People's Republic of China. The company offers screening, diagnosis, treatment, and rehabilitation services.

Interactive charts & full statements →

2609 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 1.1BCNY 1.2BCNY 1.1BCNY 803M
Gross ProfitCNY 191MCNY 208MCNY 178MCNY 80M
Operating Income (EBIT)CNY 24MCNY 32MCNY 22M(CNY 39M)
Net Income(CNY 13M)(CNY 14M)(CNY 26M)(CNY 58M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2609 Free Cash Flow History

2609 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 2.6BCNY 2.2BCNY 2.2BCNY 2.1B
Total LiabilitiesCNY 936MCNY 1.0BCNY 1.0BCNY 1.0B

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2609 viewer.

Other Companies in Medical Care Facilities

← 2608All “0-9” companies2610 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.